Asian Spectator

Business & Finance Asia

Jacobson Pharma Launches First Influenza/RSV Home Diagnostic Kit in Hong Kong and Macau

  • Written by Jacobson Pharma Corporation Limited

HONG KONG, CHINA - Media OutReach[1] - 5 February 2020 - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in research, development, production, marketing and sale of generic drugs and branded healthcare products, announced the launch of its first home diagnostic product for influenza/RSV under the brand name of "Dr. Freeman Flu/RSV Combo" (the "Product") in Hong Kong and Macau since January 2020. The product is available in different over-the-counter channels including major healthcare chain stores and drug stores.

 

Jacobson Pharma Launches First Influenza/RSV Home Diagnostic Kit in Hong Kong and Macau

Jacobson launches Dr. Freeman Flu/RSV Combo as its first influenza/RSV home diagnostic kit in the markets of Hong Kong and Macau. It is designed for qualitative determination of specific types of Influenza A and B virus and respiratory syncytial virus ("RSV") with test results available in 8 minutes.

Dr. Freeman Flu/RSV Combo is a handy one-step home diagnostic test designed for qualitative determination of specific types of Influenza A and B virus and respiratory syncytial virus ("RSV") with test results available in 8 minutes. The Product marks the first among others of its home diagnostic portfolio to be launched under the branded healthcare business platform of the Group. The Group is contemplating a potential strategic spin-off of its branded healthcare business which comprises proprietary medicines, proprietary Chinese medicines and branded health and wellness products such as health supplements, personal care products and diagnostic kits.

 

In scientific terms, Dr. Freeman Flu/RSV Combo uses monoclonal antibodies specific to the corresponding antigens of influenza and RSV for determination of the specific types of influenza and RSV infected, apart from the indication of the presence of influenza.

 

Mr Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma, commented, "We are very pleased for bringing in this useful home diagnostic product for influenza /RSV to the markets in Hong Kong and Macau. As a handy, speedy and specific self-diagnostic tool for the communicable disease, we believe the Product can highly benefit the public by helping influenza/RSV infected patients to seek prompt and effective medical treatment at the onset of the illnesses, especially during the peak flu seasons.

 

Bearing with the commitment to fulfilling unmet healthcare needs of consumers, we will continue to enhance our portfolio with high quality, innovative and well-trusted products in the expansion of our branded healthcare business as a strategic growth platform. Our ongoing efforts are set to strengthen our long-term strategic position and thereby enhancing the shareholders' values. ".

References

  1. ^ Media OutReach (www.media-outreach.com)

Authors: Jacobson Pharma Corporation Limited

Read more http://www.media-outreach.com/release.php/View/27649#Contact

Global Industry Leaders Highlighted Food Safety Issues in Times of Pandemic at the 6th Food Safety Forum

GS1 HK Launches Trusted FoodNet to Promote Information Visibility HONG KONG SAR - Media OutReach - 15 January 2021 - The 6th Food Safety Forum organised by GS1 Hong Kong (GS1 HK) c...

Prince Albert of Monaco to deliver keynote address at Abu Dhab...

ABU DHABI, United Arab Emirates, Jan. 16, 2021 /PRNewswire-AsiaNet/-- - Reimagined ADSW 2021 comprises high-level virtual events including ADSW Summit, IRENA Assembly, Abu Dhabi Sustainable ...

The China International Import Expo, a boost to global service...

SHANGHAI, Jan. 16, 2021 /PRNewswire-AsiaNet/ -- China was in 2019 ranked third in the world, behind the United States and Singapore, in terms of digital economy competitiveness, according to...

Jacobson Pharma's Proposed Spin-off and Separate Listing of JBM (Healthcare) Limited on The Main Board of The Stock Exchange of Hong Kong Limited

HONG KONG, Jan 15, 2021 - (ACN Newswire) - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development...

Harbin Harnesses Ice, Snow for Tourism Growth

HARBIN, China, Jan. 15, 2021 /PRNewswire-AsiaNet/ -- The 33rd Harbin Sun Island International Snow Sculpture Art Exposition recently kicked off in Harbin, capital of northeast China's Heilon...

Huion KD200: The Innovative Combination of Keyboard and Pen Ta...

SHENZHEN, China, Jan. 15, 2021 /PRNewswire-AsiaNet/ -- Global digital painting device provider Huion launched its award-winning pen tablet KD200 recently. Equipped with a one-hand keyboard a...

Moonstake Wallet Officially Commences Staking Support for QURAS

SINGAPORE, Jan 15, 2021 - (ACN Newswire) - Today, Moonstake announced the support of staking Quras's cryptocurrency XQC in Moonstake's Web and Mobile Wallets. In April of last year, Moonsta...

Magazine

Australian startup CareApp receives funding injection to expand app

Australian based startup CareApp has recently raised over $500,000 in funding including $250,000 provided by the South Australian State Government to rapidly expand and scale up their smartphone...

Shaparency launches to enable businesses to go fully digital

New venture developed for post-Covid-19 corporate landscape London-based start-up Shaparency, which has been established in response to the business conditions resulting from Covid-19, announces ...

Specops Significant Cyber Attacks

The prevalence and severity of cyber attacks are increasing at an alarming rate every year. So much so, that statistics from Cybersecurity Ventures estimate that cybercrime will cost the global ...

Writers Wanted



News Co Media Group

Content & Technology Connecting Global Audiences

More Information - Less Opinion